ArticleProceedings of the National Academy of Sciences of the United States of America2017

PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI/SNF mutant tumors.

Thomas Januario et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.